1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow GSK4527363: new trials by email Literature Review of GSK4527363 trials Research Report on GSK4527363
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants GSK4527363, Placebo matching GSK4527363, Belimumab - Systemic Lupus Erythematosus | Phase 1 | Recruiting | GlaxoSmithKline | 142 | 2024-09-02 | 2026-06-22 |
Connective Tissue Diseases (1) · Lung Diseases, Interstitial (1) · Lupus Erythematosus, Systemic (1)
GlaxoSmithKline (1)
Argentina (1) · Brazil (1) · Poland (1) · Spain (1) · United Kingdom (1) · United States (1)